2.50
Hdl Handle:
http://hdl.handle.net/10755/154915
Type:
Presentation
Title:
Parallel Measures of Insomnia Severity Rating in Breast Cancer Survivors
Abstract:
Parallel Measures of Insomnia Severity Rating in Breast Cancer Survivors
Conference Sponsor:Sigma Theta Tau International
Conference Year:2005
Author:Epstein, Dana, RN, PhD
P.I. Institution Name:Carl T. Hayden VA Medical Center
Title:associate chief nurse for research
Co-Authors:Shannon Dirksen, RN, PhD
One approach to the measurement of insomnia, the Insomnia Severity Index (ISI), was used in an insomnia intervention study for breast cancer survivors. The ISI is a practical, reliable, and valid instrument (Bastien et al., 2001). The purpose of this paper is to examine the ratings of insomnia severity from study participants, significant others, and the nurse therapist at pre- and post-treatment. Breast cancer survivors who were at least 3 months post completion of primary cancer treatment and without active disease were randomly assigned to either theory-driven multi-component intervention (MCI) or a component comparison group (CC). Seventy-two women, 32 significant others, and the research nurse therapist completed pre and post-treatment ISI assessments. Data were examined using Pearson correlation coefficients and repeated measures analysis of variance (ANOVA). Seventy-two women (mean age=58.2 years, SD=10.3; mean insomnia duration=5.2 years, SD=6.7) participated. Prior to treatment, the participants' and therapist ISI scores were correlated (r=.33, p=.004). For the MCI group post-treatment, the participant score was correlated with the significant other (r=.60, p=.01) and the therapist (r=.56, p=.001) ratings. The participant and therapist ratings were correlated (r=.42, p=.01) post-treatment in the CC group. The repeated measures ANOVAs revealed significant group by time interactions for the participants and clinicians (ps= .01), and a significant time effect for the significant others (p= .000). Pairwise comparisons showed a pre to post-treatment decrease in insomnia severity by all raters for both groups. Similar ratings of insomnia were found primarily between the participants and the therapist. Participants in both groups rated themselves as improved after treatment, and the significant others and therapist ratings paralleled the findings. Possible explanations for pre and post-treatment associations among raters and the improvement in both groups will be discussed. The clinical usefulness of the instrument and findings will be examined. Funding: The National Cancer Institute CA91869
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleParallel Measures of Insomnia Severity Rating in Breast Cancer Survivorsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/154915-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Parallel Measures of Insomnia Severity Rating in Breast Cancer Survivors</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Epstein, Dana, RN, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Carl T. Hayden VA Medical Center</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">associate chief nurse for research</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">dana.epstein@med.va.gov</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Shannon Dirksen, RN, PhD</td></tr><tr><td colspan="2" class="item-abstract">One approach to the measurement of insomnia, the Insomnia Severity Index (ISI), was used in an insomnia intervention study for breast cancer survivors. The ISI is a practical, reliable, and valid instrument (Bastien et al., 2001). The purpose of this paper is to examine the ratings of insomnia severity from study participants, significant others, and the nurse therapist at pre- and post-treatment. Breast cancer survivors who were at least 3 months post completion of primary cancer treatment and without active disease were randomly assigned to either theory-driven multi-component intervention (MCI) or a component comparison group (CC). Seventy-two women, 32 significant others, and the research nurse therapist completed pre and post-treatment ISI assessments. Data were examined using Pearson correlation coefficients and repeated measures analysis of variance (ANOVA). Seventy-two women (mean age=58.2 years, SD=10.3; mean insomnia duration=5.2 years, SD=6.7) participated. Prior to treatment, the participants' and therapist ISI scores were correlated (r=.33, p=.004). For the MCI group post-treatment, the participant score was correlated with the significant other (r=.60, p=.01) and the therapist (r=.56, p=.001) ratings. The participant and therapist ratings were correlated (r=.42, p=.01) post-treatment in the CC group. The repeated measures ANOVAs revealed significant group by time interactions for the participants and clinicians (ps= .01), and a significant time effect for the significant others (p= .000). Pairwise comparisons showed a pre to post-treatment decrease in insomnia severity by all raters for both groups. Similar ratings of insomnia were found primarily between the participants and the therapist. Participants in both groups rated themselves as improved after treatment, and the significant others and therapist ratings paralleled the findings. Possible explanations for pre and post-treatment associations among raters and the improvement in both groups will be discussed. The clinical usefulness of the instrument and findings will be examined. Funding: The National Cancer Institute CA91869</td></tr></table>en_GB
dc.date.available2011-10-26T13:22:54Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T13:22:54Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.